Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients

Clinical trial NCT05114421 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05114421
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High Grade Fallopian Tube Serous Adenocarcinoma High Grade Ovarian Serous Adenocarcinoma Peritoneal High Grade Serous Adenocarcinoma Recurrent High Grade Fallopian Tube Serous Adenocarcinoma Recurrent High Grade Ovarian Serous Adenocarcinoma Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma

Start date: 2021-11-09
Primary completion: 2027-01-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.